News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
428 Results
Type
Article (2)
Press Release (426)
Section
Business (176)
Deals (27)
Drug Development (1)
News (199)
Policy (4)
Tag
Academia (1)
Alliances (21)
Asia (3)
C2C Services and Suppliers (33)
California (1)
Clinical research (1)
Diagnostics (1)
Earnings (109)
Europe (5)
Events (64)
Executive appointments (1)
Healthcare (13)
Hotbed/Location (346)
Illinois (1)
IPO (10)
Legal (3)
Medical device (7)
Medtech (7)
Mergers & acquisitions (17)
NextGen Class of 2024 (1)
Non-profit (1)
People (45)
Phase I (1)
Real estate (1)
Regulatory (1)
United States (2)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (9)
2024 (6)
2023 (12)
2022 (38)
2021 (40)
2020 (49)
2019 (37)
2018 (26)
2017 (21)
2016 (28)
2015 (33)
2014 (19)
2013 (17)
2012 (7)
2011 (15)
2010 (9)
428 Results for "omnicell".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Omnicell Announces First Quarter 2024 Results
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024.
May 2, 2024
·
30 min read
Business
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024.
April 8, 2024
·
1 min read
Business
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
Omnicell, Inc. today announced results for its fiscal year and fourth quarter ended December 31, 2023.
February 8, 2024
·
39 min read
Business
Omnicell Elects Eileen Voynick to Board of Directors
Omnicell, Inc., a leader in transforming the pharmacy care delivery model, announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024.
January 11, 2024
·
5 min read
Business
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024.
January 16, 2024
·
1 min read
Business
Omnicell Appoints Bobby Ghoshal to Board of Directors
Omnicell, Inc. today announced it has increased its number of board seats from 9 to 10, and has appointed Kaushik “Bobby” Ghoshal to fill the newest seat as an independent director of Omnicell’s Board of Directors, effective immediately.
July 11, 2023
·
6 min read
Lone Star Bio
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m. ET.
November 27, 2023
·
1 min read
Business
Omnicell Announces Third Quarter 2023 Results; Updates Fiscal Year 2023 Guidance and Announces Reduction in Force
Omnicell, Inc. today announced results for its third quarter ended September 30, 2023.
November 2, 2023
·
36 min read
Business
Omnicell Announces Second Quarter 2023 Results
Omnicell, Inc., a leader in transforming the pharmacy care delivery model, announced results for its second quarter ended June 30, 2023.
August 1, 2023
·
33 min read
Business
Omnicell to Release Third Quarter 2023 Financial Results on November 2, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2, 2023.
October 16, 2023
·
1 min read
1 of 43
Next
